top of page

About
Science
News
Careers

What's new

All news
Highlights
Media releases
Events

Obulytix at ESCMID Global 2026: advancing the dialogue on next-generation antimicrobials

Obulytix at ESCMID Global 2026: advancing the dialogue on next-generation antimicrobials

Obulytix at ESCMID Global 2026: advancing the dialogue on next-generation antimicrobials

Apr 23

analyseren van culturen, laboratoriumtechniek: steriele handschoenen en pipetten, bestuderen hoe pathogenen reageren op behandelingen

analyseren van culturen, laboratoriumtechniek: steriele handschoenen en pipetten, bestuderen hoe pathogenen reageren op behandelingen

Obulytix featured in Euractiv’s article ‘Belgian biotech AMR breakthrough as WHO warns antibiotic pipeline is failing’

Mar 17

Obulytix at the AMR Conference (Basel, March 3-4, 2026)

Obulytix at the AMR Conference (Basel, March 3-4, 2026)

Obulytix at the AMR Conference (Basel, March 3-4, 2026)

Feb 4

END2AMR launches to accelerate innovation against drug-resistant bacterial infections

END2AMR launches to accelerate innovation against drug-resistant bacterial infections

END2AMR launches to accelerate innovation against drug-resistant bacterial infections

Dec 19, 2025

Erlenmeyer gevuld met een donkere vloeistof, laboratoriumomgeving op de achtergrond is een rek met reageerbuizen zichtbaar

Erlenmeyer gevuld met een donkere vloeistof, laboratoriumomgeving op de achtergrond is een rek met reageerbuizen zichtbaar

Obulytix is developing a revolutionary solution for antibiotic resistance

Dec 5, 2023

Site

Office & Labs

Suzanne Tassierstraat 1 

9052 Gent, Belgium

+32(0)9 229 06 92

info@obulytix.com

Socials

Pioneering a novel class of precision biologics

© 2025 by Obulytix. Webdesign by marsmedia.nl | Privacy Policy | Terms of use

About
Science
News
Careers

bottom of page